NAVLE Multisystemic

Feline Insecticide Toxicity Study Guide

Insecticide toxicity represents one of the most commonly encountered toxicoses in feline emergency medicine.

Overview and Clinical Importance

Insecticide toxicity represents one of the most commonly encountered toxicoses in feline emergency medicine. Cats are uniquely susceptible to certain insecticides due to their deficient hepatic glucuronidation pathway, which impairs metabolism of many compounds that are relatively safe in other species. The three major classes of insecticides causing feline toxicosis are pyrethrins/pyrethroids, organophosphates/carbamates, and amitraz. Understanding the distinct mechanisms, clinical presentations, and treatment protocols for each class is essential for both clinical practice and NAVLE success.

Type Examples Clinical Syndrome
Type I Permethrin, Allethrin, Phenothrin, Resmethrin T-syndrome: Fine tremor progressing to whole-body tremor, hyperexcitability, prostration
Type II Cypermethrin, Deltamethrin, Fenvalerate, Cyfluthrin CS-syndrome: Choreoathetosis, profuse salivation, seizures

Section 1: Pyrethrin and Pyrethroid Toxicity

Etiology and Source

Pyrethrins are naturally occurring insecticidal compounds derived from Chrysanthemum cinerariifolium (Dalmatian pyrethrum) and Chrysanthemum coccineum (Persian pyrethrum). Pyrethroids are synthetic derivatives with enhanced photostability and potency. Permethrin is the most clinically significant pyrethroid in feline toxicosis.

Primary exposure routes: The most common cause is inappropriate application of dog flea/tick products containing 40-65% permethrin to cats. Secondary exposure occurs through grooming contact with recently treated dogs or ingestion of flea collars.

High-YieldPermethrin spot-on products labeled "for dogs only" containing greater than 40% permethrin are the number one cause of feline pyrethroid toxicosis. Low-concentration products (0.05-0.1%) approved for cats are generally safe when used as directed.

Mechanism of Action

Pyrethrins and pyrethroids are neurotoxicants that act on voltage-gated sodium channels in nerve and muscle cell membranes. They prolong sodium channel opening, preventing normal repolarization and causing repetitive nerve firing.

Why cats are susceptible: Cats possess deficient hepatic glucuronosyltransferase activity, resulting in impaired glucuronide conjugation. This metabolic pathway is essential for detoxifying pyrethroids. Phase I metabolites accumulate and are more potent than the parent compound, leading to prolonged toxicity.

Pyrethroid Classification and Clinical Syndromes

Clinical Signs

Onset: Clinical signs typically appear within minutes to hours of exposure but may be delayed up to 72 hours. Duration is typically 2-3 days with treatment, though some cases require 5-7 days for complete resolution.

NAVLE TipThe classic NAVLE presentation is a cat with acute onset of tremors, hypersalivation, and seizures after the owner applied a "flea product" - always ask specifically whether a DOG product was used!

Diagnosis

Diagnosis is primarily based on history of exposure combined with characteristic clinical signs. No rapid in-house test exists. Skin/hair samples can be analyzed for pyrethroid content, but results are not available acutely and there are no established toxic threshold values for cats.

Differential diagnoses: Strychnine, amphetamines/pseudoephedrine, bromethalin, tremorgenic mycotoxins, organophosphate/carbamate toxicity, nicotine, lead, hypoglycemia, hypocalcemia, hepatic encephalopathy, epilepsy, and encephalitis.

Treatment Protocol

1. Stabilization and Seizure/Tremor Control

2. Decontamination

After stabilization, bathe the cat with lukewarm water and mild liquid dish soap (e.g., Dawn) to remove residual product. Avoid scrubbing aggressively. Monitor temperature closely during and after bathing as hypothermia is a common and serious complication.

3. Intravenous Lipid Emulsion (ILE) Therapy

ILE is an emerging adjunctive therapy for lipophilic toxins including pyrethroids. Permethrins are highly fat-soluble, making them excellent candidates for lipid rescue therapy.

Protocol: 20% Intralipid at 1.5 mL/kg IV bolus over 15-30 minutes, followed by 0.25 mL/kg/min CRI for 30-60 minutes through a dedicated IV line. May repeat after 6-8 hours if signs persist and serum is not grossly lipemic.

High-YieldILE therapy has shown rapid clinical improvement and reduced hospitalization time (24-54 hours vs. 72+ hours with conventional treatment alone). It works by creating a "lipid sink" that sequesters fat-soluble toxins away from target tissues.

4. Supportive Care

IV fluid therapy for hydration and myoglobin protection. Active temperature monitoring and management (warming if hypothermic, cooling if hyperthermic). Blood glucose monitoring (hypoglycemia can occur with prolonged seizures). Oxygen supplementation if respiratory distress present.

Prognosis

Excellent with prompt treatment - survival rates exceed 95% when intervention occurs within hours of exposure. Mortality is associated with delayed presentation (greater than 24 hours), young kittens, and development of complications such as aspiration pneumonia, rhabdomyolysis, or DIC. Most cats are discharged within 24-48 hours with appropriate treatment.

System Clinical Signs
Neurologic (most common) Muscle fasciculations, generalized tremors, hyperesthesia, hyperexcitability, ataxia, seizures, mydriasis, temporary blindness (rare)
Autonomic Hypersalivation, tachypnea, tachycardia
Thermoregulatory Initial hyperthermia (from tremoring), then hypothermia post-bathing and after tremor control
Cutaneous Paresthesia (cats may roll and rub affected areas), ear twitching, paw flicking

Section 2: Organophosphate and Carbamate Toxicity

Etiology and Source

Organophosphates (OPs) and carbamates are acetylcholinesterase-inhibiting insecticides. Common OPs include chlorpyrifos, diazinon, malathion, and dichlorvos. Common carbamates include carbaryl, propoxur, methomyl, and carbofuran.

Exposure sources: Agricultural pesticides, lawn/garden products, flea collars, dips, and sprays. Malicious poisoning occurs, particularly with highly toxic compounds like aldicarb and carbofuran.

Mechanism of Action

Both classes inhibit acetylcholinesterase (AChE), the enzyme responsible for breaking down acetylcholine at cholinergic synapses. This results in accumulation of acetylcholine and overstimulation of muscarinic receptors, nicotinic receptors, and CNS cholinergic pathways.

Key difference: OPs cause irreversible phosphorylation of AChE (leading to "aging" of the enzyme), while carbamates cause reversible carbamylation that spontaneously hydrolyzes within 24-48 hours. This has important treatment implications.

Clinical Signs: The Cholinergic Toxidrome

Clinical signs are classified by receptor type: muscarinic, nicotinic, and central. The classic muscarinic presentation is remembered with the mnemonics SLUDGE or DUMBELS.

High-YieldThe "Killer Bs" are the life-threatening muscarinic effects: Bradycardia, Bronchospasm, and Bronchorrhea. Death typically occurs from respiratory failure due to bronchial secretions, bronchospasm, and respiratory muscle paralysis.

Diagnosis

Diagnosis is based on exposure history, cholinergic toxidrome, and response to atropine ("atropine challenge"). Laboratory confirmation includes measurement of blood or serum cholinesterase activity. Inhibition greater than 50% is confirmatory; signs typically appear with greater than 70% inhibition. Brain cortex cholinesterase can be measured postmortem.

Treatment Protocol

NAVLE TipPralidoxime is indicated for OPs but is controversial for pure carbamate toxicity because carbamates spontaneously dissociate from AChE. However, in unknown or mixed exposures, 2-PAM should be administered since it is unlikely to be harmful and may be life-saving if an OP is involved.

Decontamination

Dermal: Bathe with detergent and lukewarm water after stabilization. Oral: If no clinical signs and ingestion was non-liquid, consider inducing emesis with 3% hydrogen peroxide followed by activated charcoal (1-2 g/kg PO). AVOID emesis for liquid products due to aspiration risk from hydrocarbon solvents.

Prognosis

In one retrospective study of 39 cats, mortality was 15%. Low respiratory rate and hypothermia at presentation were associated with death. Carbamate toxicity generally has a better prognosis than OP toxicity due to reversible enzyme inhibition. Intermediate syndrome may occur 24-96 hours post-exposure with respiratory muscle paralysis.

Drug Dose Notes
Methocarbamol 44-220 mg/kg IV slowly; do not exceed 330 mg/kg/day FIRST-LINE for tremor control; give half dose rapidly, remainder to effect
Diazepam 0.5-1.0 mg/kg IV PRN For seizure control; may paradoxically worsen tremors if used alone
Propofol 1 mg/kg IV bolus, then 0.1 mg/kg/min CRI For refractory seizures/tremors
Phenobarbital 4-16 mg/kg IV PRN Alternative for seizure control

Section 3: Amitraz Toxicity

Etiology and Source

Amitraz is a triazapentadiene (formamidine) insecticide and acaricide used primarily in tick collars and mange treatments for dogs. It is contraindicated in cats due to their narrow therapeutic margin. Exposure occurs through inappropriate application of dog products or ingestion of tick collars.

Mechanism of Action

Amitraz is an alpha-2 adrenergic agonist that also inhibits monoamine oxidase (MAO) and prostaglandin synthesis. In insects, it stimulates octopamine receptors. The alpha-2 agonism is responsible for most clinical signs and explains why alpha-2 antagonists are effective antidotes.

Clinical Signs

Onset: Signs typically appear within 30 minutes to 2 hours of exposure. The clinical picture reflects alpha-2 adrenergic stimulation.

High-YieldThe combination of sedation, bradycardia, hypothermia, and hyperglycemia with mydriasis should trigger suspicion for amitraz toxicity - this profile reflects alpha-2 agonism. Remember: amitraz acts like a "chemical xylazine"!

Treatment Protocol

Additional management: If collar ingestion, consider endoscopic retrieval. Emesis may be induced if recent ingestion and no clinical signs. Activated charcoal may be helpful but use cautiously due to GI stasis. Supportive care includes IV fluids, temperature support, and monitoring.

NAVLE TipAtipamezole is preferred over yohimbine in cats because of its greater alpha-2 receptor affinity and fewer cardiorespiratory side effects. This is the same drug used to reverse medetomidine/dexmedetomidine sedation!
Mnemonic Signs
SLUDGE (Muscarinic) Salivation, Lacrimation, Urination, Defecation, GI distress, Emesis
DUMBELS (Muscarinic) Diarrhea, Urination, Miosis, Bradycardia/Bronchospasm/Bronchorrhea, Emesis, Lacrimation, Salivation
Nicotinic Signs Muscle fasciculations, tremors, weakness, paralysis, tachycardia, mydriasis, respiratory failure
CNS Signs Anxiety, restlessness, seizures, ataxia, coma, respiratory depression

Comparison of Feline Insecticide Toxicoses

Drug Dose (Cats) Mechanism and Notes
Atropine sulfate 0.2-0.5 mg/kg; 1/4 IV, 3/4 SC; repeat PRN Competitive muscarinic antagonist. Endpoint: cessation of bronchial secretions, NOT mydriasis. Does NOT reverse nicotinic effects.
Pralidoxime (2-PAM) 20-50 mg/kg slow IV or IM; repeat at half dose PRN Reactivates AChE by nucleophilic attack on phosphorus. Must give within 24-48 hours before "aging" occurs. For OPs primarily; controversial for carbamates.
Diazepam 0.5-1.0 mg/kg IV PRN For seizure control
System Clinical Signs
CNS Profound sedation, lethargy, ataxia, loss of reflexes, CNS depression
Cardiovascular Bradycardia, hypotension, weak pulses
Ocular Mydriasis (bilateral)
Thermoregulatory Hypothermia
Metabolic Hyperglycemia (alpha-2 mediated inhibition of insulin release)
GI Vomiting, hypersalivation, GI stasis, decreased intestinal transit
Drug Dose (Cats) Notes
Atipamezole (Antisedan) 0.05-0.1 mg/kg IM PREFERRED alpha-2 antagonist for cats. Rapid reversal within 10-20 minutes. Higher affinity for alpha-2 receptors than yohimbine.
Yohimbine 0.1-0.2 mg/kg slow IV or IM Alternative alpha-2 antagonist. May cause significant tachycardia and tachypnea. Repeat every 1.5-2 hours PRN.
Feature Pyrethroid OP/Carbamate Amitraz
Mechanism Na+ channel prolongation AChE inhibition Alpha-2 agonism
Key Signs Tremors, seizures, hypersalivation SLUDGE, bradycardia, miosis Sedation, bradycardia, mydriasis
Pupil Size Mydriasis Miosis Mydriasis
Heart Rate Tachycardia Bradycardia Bradycardia
Blood Glucose Hypoglycemia (seizures) Variable Hyperglycemia
Primary Antidote Methocarbamol Atropine + 2-PAM Atipamezole

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →